Liraglutide reduces hyperglycaemia and body weight in overweight, dysregulated insulin‐pump‐treated patients with type 1 diabetes: The Lira Pump trial—a randomized, double‐blinded, placebo‐controlled trial
1. 系统已在2026-10-10 12:02:18对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1111/dom.13911
文献链接: https://dom-pubs.pericles-prod.literatumonline.com/doi/10.1111/dom.13911
其他信息:
出版社: Wiley
作者: Thomas F. Dejgaard; Signe Schmidt; Christian S. Frandsen; Dorte Vistisen; Sten Madsbad; Henrik U. Andersen; Kirsten Nørgaard
全文下载地址: https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fdom.13911

